TCT 2018 | LRP: Infrared Technology for the Detection of Vulnerable Patients and Plaques

Despite optimal medical treatment and modification of risk factors, patients may spend long periods without symptoms and then experience acute coronary syndrome without any prior indication that may allow us to predict the time of occurrence.

TCT 2018 | LRP: tecnología infrarroja para detectar pacientes y placas vulnerablesThis is why the possibility of detecting patients with vulnerable plaques and who are at higher risk is very important.

 

Near-infrared spectroscopy (NIRS) is available with a dual catheter for intravascular ultrasound (IVUS).

 

This study included 1563 patients with suspected coronary disease. NIRS-IVUS imaging was performed in two or more arteries, and patient- and artery-level analyses were carried out.

 

As regards the patient-level analysis, the risk of experiencing an event within 24 months for each 100-unit increase in maxLCBI4mm (lipid load index by NIRS) was 18%. The risk was 12.6% higher with maxLCBI4mm ≥400, compared with 6.3% for patients with maxLCBI4mm <400.

 

NIRS seems to be far from clinical practice, but it may help with the detection of non-culprit plaque or in patients who are at high risk of developing it in the future.

 

Original title: LRP (LIPID RICH PLAQUE STUDY) Assessment of Coronary Near-Infrared Spectroscopy Imaging to Detect Vulnerable Plaques and Vulnerable Patients.

Presenter: Ron Waksman.

 

LIPID-RICH-PLAQUE-STUDY-presentación


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....